| Karen E Mccarty, RN | |
|
1607 N Lincoln St, Knoxville, IA 50138-3455 | |
| (641) 828-5019 | |
| Not Available |
| Full Name | Karen E Mccarty |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - General Practice |
| Location | 1607 N Lincoln St, Knoxville, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750063558 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WG0000X | Registered Nurse - General Practice | 088723 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen E Mccarty, RN 1607 N Lincoln St, Knoxville, IA 50138-3455 Ph: () - | Karen E Mccarty, RN 1607 N Lincoln St, Knoxville, IA 50138-3455 Ph: (641) 828-5019 |
News Archive
A number of psychiatric disorders present with aggression and violence, which, needless to say, are destructive to both individuals and societies worldwide: death, disease, disability, and numerous socioeconomic problems can often be traced back to aggressive behavior.
As reported in today's Wall Street Journal, the more than 2 million Americans with atrial fibrillation are now on notice that the over-zealous marketing tactics and incentives by manufacturers of expensive medical devices which are not approved by the U.S. Food and Drug Administration (FDA) for the treatment of atrial fibrillation are likely to be influencing doctors' and hospitals' decisions about treatment for their patients' heart conditions.
New data analysis presented today at the annual Global Forum on Nicotone meeting demonstrates the potential of the low-risk tobacco product snus in reducing the impact of tobacco-related disease and death in Europe.
Vivek Reddy, MD, Director of Arrhythmia Services for The Mount Sinai Hospital, reported his promising12-month follow-up data showing the world's first leadless pacemaker is demonstrating overall device performance comparable to conventional pacemakers. Dr. Reddy presented the one-year LEADLESS study data findings during his late-breaking clinical trial presentation on May 9 at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions in San Francisco, CA.
The U.S. Food and Drug Administration today approved the Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. Natrelle 410 implants are manufactured by Allergan, Inc.
› Verified 2 days ago
Alexa Michelle Peterson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1607 N Lincoln St, Knoxville, IA 50138 Phone: 641-828-5019 | |
Twyla Renae Hoover, BSN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 806 S Dayton St, Knoxville, IA 50138 Phone: 641-891-3115 | |
Mary A Robb, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1515 W Pleasant St, Knoxville, IA 50138 Phone: 641-842-3101 | |
Natalie Brady, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1607 N Lincoln St, Knoxville, IA 50138 Phone: 641-828-5132 | |
Sonya Test, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1777 B Ave, Knoxville, IA 50138 Phone: 515-587-0291 | |
Erin Michelle Dingman, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1607 N Lincoln St, Knoxville, IA 50138 Phone: 641-828-5019 |